Preclinical antibacterial pipeline

The global preclinical antibacterial pipeline is characterized by a high level of diversity and interesting scientific concepts, although this innovative potential does not necessarily solve the most critical therapeutic problems and may not translate to relevant clinical effects. This analysis of 407 projects from 314 insti-tutions is the first study to provide a snapshot of the current global preclinical activities. More here…